+ All Categories
Home > Documents > Overview

Overview

Date post: 05-Feb-2016
Category:
Upload: orsin
View: 17 times
Download: 0 times
Share this document with a friend
Description:
Assessing Risk from Environmental Exposure to Waterborne Pathogens: Use of Dynamic, Population-Based Analytical Methods and Models May 11, 2005. - PowerPoint PPT Presentation
Popular Tags:
51
Assessing Risk from Environmental Exposure to Waterborne Pathogens: Use of Dynamic, Population-Based Analytical Methods and Models May 11, 2005 This lecture is based on lecture material prepared by Prof. Joe Eisenberg, formerly of the University of California-Berkeley and now at the University of Michigan Used with his permission
Transcript
Page 1: Overview

Assessing Risk from Environmental Exposure to Waterborne

Pathogens: Use of Dynamic, Population-Based

Analytical Methods and Models

May 11, 2005

This lecture is based on lecture material prepared by Prof. Joe Eisenberg, formerly of the University of California-Berkeley and now at the University of Michigan

Used with his permission

Page 2: Overview

Overview Role of water in disease burden

– Water as a route of disease transmission Methods of risk estimation

– Direct: intervention trials– Indirect: risk assessment

Population-level risks– Example: the Milwaukee outbreak

Page 3: Overview

Importance of Waterborne Pathogens

Domestic: U.S. interest in water quality

– 1993 Cryptosporidium outbreak– Increasing number of disease outbreaks

associated with water– Congressional mandates for water quality

– (Safe Drinking Water Act)

– Emphasis on risk assessment and regulation

Page 4: Overview

Importance of Waterborne Pathogens

Worldwide: WHO interest in water quality– Estimating GBD associated with water,

sanitation, and hygiene– Diarrheal diseases are a major cause of

childhood death in developing countries.– 3 million of the 12.9 million deaths in

children under the age of 5 attributable to diarrheal disease

– Emphasis on intervention and control

Page 5: Overview

Pathways of Transmission Person-person

– Mediated through fomites (e.g., phone, sink, etc.)

– Often associated with hygiene practices Person-environment-person

– Mediated through water, food, or soil– Contamination can occur through improper

sanitation (example: sewage inflow into drinking water source or lack of latrines)

– Animals are often sources (Zoonotic pathogens)

– Exposure can occur through improper treatment of food or water

Page 6: Overview

The Disease Transmission Process

Risk estimation depends on transmission dynamics and exposure pathways

Animals

AgriculturalRunoff

DrinkingWater

2°Trans.

Recreational Waters

orWastewater reuse

Transport to other water sources

Food

Page 7: Overview

Approaches to Risk Estimation

Direct approach: The intervention trial– Can be used to assess risk from drinking

water and recreational water exposures– Problems with sensitivity (sample size

issue)– Trials are expensive.

Indirect approach: Mathematical models– Must account for properties of infectious

disease processes– Pathogen specific models– Uncertainty and variability may make

interpretation difficult.

Page 8: Overview

Approaches to Risk Estimation

Combining direct and indirect approaches– Models can define the issues

and help design studies.– Epidemiology can confirm

current model structure and provide insight into how to improve the model.

Page 9: Overview

Approaches for Risk Estimation:

Direct estimates of waterborne infectious illnesses Surveillance: count waterborne infectious

illnesses – How can a waterborne disease outbreak be distinguished from

other outbreak causes (food, fomites, etc.)?

– What about endemic disease?

Observational– Ecologic studies (e.g., serosurvey comparing communities with

and without filtration).

– Time series (e.g., correlation between turbidity and hospitalization data)

Page 10: Overview

Approaches for Risk Estimation: Distinguishing waterborne GI disease from other GI

diseases

Methods for addressing the question– In a single community: a randomized, blinded,

placebo-controlled trial– design provides an estimate of the effectiveness

of a drinking water intervention. Basic study design: two groups

“Exposed” group = normal tap water. “Treated” group = use a water treatment device

to provide water as pathogen-free as technically possible

Page 11: Overview

Approaches for Risk Estimation:

A Tap Water Intervention Trial Enroll 1000 subjects 500 receive an active home water

treatment device (and carry drinking water to work, etc. when practical)

500 receive a “placebo” home water drinking device (does nothing to change the water)

Follow the subjects for one year with daily logs of GI illness

Alternative design: Each household changes device type after 6 months.

Page 12: Overview

Approaches for Risk Estimation:

A Tap Water Intervention Trial Placebo group (tap water):

– 90 illnesses over course of the study– “Rate” = 90 / 500

Rate in placebo group = 0.18 per person per year

Treated group (active device): 60 illnesses in the treated group (active device) “Rate” = 60 / 500

Rate in treated group = 0.12 per person per year

Page 13: Overview

Approaches for Risk Estimation:

Epidemiologic Measures

Relative Risk (RR) Incidence in exposed groupIncidence in unexposed group

Interpretation: the risk of disease in the tap water group is 1.5 times higher than that of the treated group

Page 14: Overview

Approaches for Risk Estimation:

Epidemiologic Measures

Attributable Risk (AR) Incidence in exposed – Incidence in unexposed

Interpretation: There are 6 excess cases of disease per 100 subjects receiving tap water

06.012.018.0 activetapwater IncidenceIncidence

Page 15: Overview

Approaches for Risk Estimation:

Epidemiologic Measures

Attributable Risk Percent (AR%) Excess cases in exposedIncidence in exposed

Interpretation: 33% of the cases of disease in the tap water group are due to water

33.018.006.0

tapwater

tapwater

IncidenceCasesExcess

Page 16: Overview

Approaches for Risk Estimation: Epidemiologic

Measures To generalize beyond the cohort, need an

estimate of the community incidence. PAR: population attributable risk PAR%: population attributable risk % AR compares completely protected group

with completely unprotected group. PAR incorporates intermediate exposure

Page 17: Overview

Approaches for Risk Estimation: Epidemiologic

Measures Population attributable risk

Incidence in the community–incidence in the unexposed

Interpretation: In the community, 2 excess cases of disease per every 100 subjects in the community

02.012.014.0 activeComm IncidenceIncidence

Page 18: Overview

Approaches for Risk Estimation: Epidemiologic

Measures Population attributable risk percentage

Excess cases in the communityIncidence in the exposed

Interpretation: 14% of the cases of disease in the community are due to tap water

14.014.002.0

tapwater

Comm

IncidenceCasesExcess

Page 19: Overview

Approaches for Risk Estimation: Tap Water Intervention Trials

Trials in immunocompetent populations Canada (Payment)--challenged surface water

– AR = 0.35 (Study 1), 0.14-0.4 (Study 2) Australia (Fairley)--pristine surface water

– No effect Walnut Creek (UCB) – pilot trial

– AR = 0.24 (non-significant effect) Iowa (UCB)--challenged surface water

– No effect

Trials in sensitive populations HIV+ in San Francisco (UCB)--mixed sources Elderly in Sonoma (UCB)--intermediate quality surface

Page 20: Overview

Approaches for Risk Estimation:

Tap Water Intervention Trials Davenport, Iowa study

– Comparing sham vs. active groups– AR = - 365 cases/10,000/year (CI: -

2555, 1825)– Interpretation: No evidence of a

significantly elevated drinking water risk

– Is the drinking water safe?

Page 21: Overview

Approaches for Risk Estimation:

Risk Assessment vs. Intervention TrialComparing estimates from a risk assessment to randomized trial results (Eienberg et al. AJE, submitted)

Data collected during the intervention trial– Self-report illnesses from participants: Weekly diaries

– Source water quality: Cryptosporidium, Giardia, enteric viruses

– Drinking water patterns: RDD survey– Water treatment: B. subtilis, somatic coliphage

Page 22: Overview

Approaches for Risk Estimation: Risk Assessment Model

Page 23: Overview

Approaches for Risk Estimation: Risk Assessment Model Model

Cryptosporidium Giardia Viruses 1. Source water

Concentration (organisms per liter) (Normal Mean (SD)*)

1.06 (2.24)

2.68 (24.20)

0.93 (3.00)

Recovery rate 0.40 0.40 0.48 2. Treatment efficiency (logs removal)

Sedimentation and filtration (Mean (SD)*)

3.84 (0.59)

3.84 (0.59) 1.99 (0.52)

Chlorination (Mean (SD) 0 3.5 (2.93) 4 (2.93)

3. Water Consumption

in liters (mean (SD) ‡)

0.094 (0.42)

0.094 (0.42)

0.094 (0.42)

4. Dose Response § : 0.004078 : 0.01982 ,: 0.26, 0.42

5. Morbidity Ratio# 0.39 0.40 0.57

Page 24: Overview

Approaches for Risk Estimation: Risk Assessment Results

Table 2. Summary of risk estimates (cases/10,000,yr)

Cases of Illness

Mean Percentile (2.5, 97.5)

Cryptosporidium 2.1 (0.8, 3.5) Giardia 3.4 (0.6, 15.5) Enteric viruses (disinfection = 4 log removal)

8.4 (0.2, 18.7)

Enteric viruses (disinfection = 4 log removal)

0 (0, 0.2)

Overall risk estimate: 14 cases/10,000/yr

Page 25: Overview

Approaches for Risk Estimation: Comparison/Conclusions

Risk Assessment Intervention Trials

Sensitivity Not relevant Low Causal evidence Indirect Direct Pathogen inclusion Few Many Model Specification Adds uncertainty Not relevant

Transmission processes

Can be included* Only in a limited way

Distribution System effects

Can be included* Was included

Examining alternative control strategies

Yes No

Expense Low High Time Fast Slow *Was not included in this study

Table 3. Comparison of risk assessment and intervention trials

Page 26: Overview

Microbial Risk Assessment Two classes of risk assessment models

Individual-based Population-based

Individual-based estimates Risk estimates assume independence among

individuals within the population Chemical risk paradigm Focus is on direct risks Probability of disease for a given individual This probability can be either daily, yearly, our

lifetime.

Page 27: Overview

Microbial Risk Assessment

Chemical risk paradigm–Hazard identification, exposure assessment, dose

response, risk characterization Model structure

where P = probability that a single individual, exposed to N organisms, will become infected or diseased.

Exposure calculation:

))(1(1 NP

dktko

dtecVN 101

Page 28: Overview

Microbial Risk AssessmentAlternative framework: risk estimates at the population level allow for the inclusion of indirect risks due to secondary transmission

Animals

AgriculturalRunoff

DrinkingWater

2°Trans.

Recreational Watersor

Wastewater reuse

Transport to other water sources

Food

Page 29: Overview

Microbial Risk AssessmentEisenberg et al. AJE 2005

Transmission pathways – Example: a Cryptosporidium outbreak in Milwaukee Wisconsin, 1993

Competing hypotheses on the cause Oocyst contamination of drinking water influent coupled with

treatment failure Chemical risk paradigm may be sufficient (still need to

consider secondary transmission) Amplification of oocyst concentrations in the drinking water

influent due to a person-environment-person transmission process

Chemical risk paradigm cannot address this potential cause of the outbreak

Page 30: Overview

A model of disease transmission: The SIR model

Mathematical modeling of a population where individuals fall into three main categories: Susceptible (S) Infectious (I) Recovered (R)

Different individuals within this population can be in one of a few key states at any given time Susceptible to disease (S) infectious/asymptomatic (I) infectious/symptomatic (I) non-infectious/asymptomatic; recovered (R)

A dynamic model: individuals are moving from state to state over time

Page 31: Overview

The SIR model: key details

There are two sets of variables: Variables describing the states people are

in S=susceptible I=infectious R=non-infectious/asymptomatic

Variables describing how many people are moving between these states (parameters) Example: γ=Fraction of people in state R who move to

state S

Page 32: Overview

• S: Susceptible• I: Infectious (symptomatic+asymptomatic)• R: Non-infectious• W: Concentration of pathogens in the environment• β: Infection rate due to exposure to pathogen• δ: Fraction of people who move from state I to state R•γ: Fraction of people who move from state R to state S• Solid lines: Individuals moving from state to state• Dashed lines: Pathogen flows between individuals in different states

The SIR Model

ENVIRONMENTW

S R

I

Page 33: Overview

The SIR Model: slightly different version

The variables• X: susceptible• Y: infectious/asymptomatic• Z: non-infectious/asymptomatic• D: infectious/symptomatic• W: concentration of pathogens at the source• a: number of new susceptible individuals migrating in

δ+μW

X Z0+ (W) (ρ)

Dρ σ

Y

λ

a μ

Page 34: Overview

The SIR Model: slightly different version (cont)

The parameters• ρ: fraction in state Y who move to state D• α: Fraction in state Y who move to state Z• σ: Fraction in state D who move to state Z• γ: Fraction in state Z who move to state X• δ: Fraction in state D who die• μ: Fraction who die of natural causes• λ: Numbers of pathogen shed per infectious/asymptomatic individual• β0 : Baseline transmission rate• β : Infection rate due to pathogen

δ+μW

X Z0+ (W)

(ρ)

Dρ σ

Y

λ

a μ

Page 35: Overview

Dynamic Modeling of Disease Transmission: an example

XWXXZadtdX )(0

Remember: a derivative is a rate of change X= the population of individuals susceptible to a

disease dX/dt = rate of change in the susceptible population The equation describes individuals moving in and out

of the susceptible population Each variable represents some number of individuals

moving into the susceptible population (+) from some other group, out of the susceptible population (-) to some other group

Page 36: Overview

Dynamic Modeling of Disease Transmission: an example

XWXXZadtdX )(0

a= number of susceptible individuals migrating into the population

γZ =number of non-infectious/asymptomatic individuals migrating back into the susceptible population

μX =Fraction of susceptible individuals who drop out of the susceptible population because they die of natural causes

β0X =number of susceptible individuals who become infected and drop out of the susceptible population

β(W)X =number of susceptible people becoming ill due to pathogen exposure and drop out of the susceptible population

Page 37: Overview

Analysis of Disease Transmission Models

Traditional approaches to evaluating dynamics models are qualitative – Stability analysis, threshold estimates

(Ro), qualitative fits– Statistics rarely used to analyze output

Methodological goal to obtain public health relevant estimates of the outbreak– Need to modify traditional statistical

techniques to address models with large number of parameters, sparse data, and collinearity

Page 38: Overview

Analysis of Disease Transmission Models

LikelihoodTraditional likelihood methods

– Difficult to find maximum likelihood point in highly parameterized models.– Confidence intervals are often not possible in complex likelihood spaces

Profile likelihood is an alternative option– Fix a subset of the parameters across a grid of values.– At each point in the grid the remaining parameters are maximized.

Bayesian techniques Practical for combining outbreak data with existing information about parameters. Modifications required to deal with collinearities

Page 39: Overview

Model 1

Goals:To examine the role of person-person (secondary)

transmission

To estimate the fraction of outbreak cases associated with person-person (secondary) transmission

Page 40: Overview

Cryptosporidium Outbreak - Model Diagram

S(t)Susceptible E1 E2 Ek

IA(t) Infectious

(asymptomatic)

R(t) Removed

W(t)Environmental Transmission

...

Latently Infected IS(t)Infectious

(symptomatic)

+ S

S: SusceptibleW: Concentration of Pathogens in the EnvironmentIS: Symptomatic and Infectious IA: Asymptomatic and InfectiousR: Immune/ Partially ProtectedSolid: Individual Flows from State to StateDashed: Pathogen Flows

Page 41: Overview

Analysis - Model 1Monte Carlo Markov Chain (MCMC) was used to

generate a posterior distribution.Two step procedure was used to address collinearities

of the parameter estimates– MCMC at profiled points– Second MCMC on draws from first MCMC

Cumulative incidence, I1, was produced by a random draw of the posterior

Cumulative incidence, I0, was produced by first setting bs=0 then obtaining a random draw of the posterior.

The attributable risk associated with secondary transmission was I1- I0

Page 42: Overview

Risk Attributable to Secondary

Transmission10% , 95% CI [6, 21]

0 0.1 0.2 0.3 0.4 0.50

100

200

300

400

500

600

700

Percent attributable risk

Freq

uenc

y

Page 43: Overview

Model 2Goal:

To examine the role of person-environment-person transmission

To estimate the preventable fraction due to an increase in distance between wastewater outlet and drinking water inlet

Examine preventable fraction as a function of transport time parameter, d

– Where d is a surrogate for the potential intervention of moving the drinking water inlet farther from the wastewater outlet

Page 44: Overview

Cryptosporidium Outbreak- Model Diagram

S(t)Susceptible E1 E2 Ek

IA(t) Infectious

(asymptomatic)

R(t) Removed

W(t)Environmental Transmission

...

Latently Infected IS(t)Infectious

(symptomatic)

+ S

S: SusceptibleW: Concentration of Pathogens in the EnvironmentIS: Symptomatic and InfectiousIA: Asymptomatic and InfectiousR: Immune/ Partially ProtectedSolid: Individual Flows from State to StateDashed: Pathogen Flows

Page 45: Overview

Analysis - Model 2

Estimate the likelihood for different values of d, ranging from 1 - 40 days.

Estimate the attack rate (AR) for the MLE parameters

Estimate the AR for different values of d, keeping all other parameters constant at their MLE values.

Plot PFd = 1 - ARMLE / ARd

Page 46: Overview

Profile Likelihood of the Delay Parameter

0 5 10 15 20 25 30 35 40-2480

-2475

-2470

-2465

-2460

-2455

-2450

Days

Log

Like

lihoo

d

MLE for the time between contamination of sewage and exposure from drinking water tap was 11 days

(95% CI [8.3, 19])

Page 47: Overview

Preventable Fraction As a Function of Delay Time

Predicting the public health benefits of moving the drinking water inlet

0 5 10 15 20 25 30 35 40 450

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

Days

Pre

vent

able

Fra

ctio

n

Page 48: Overview

Conclusions Secondary transmission was small.

– Best guess is 10%, most likely less than 21%

– Consistent with empirical findings of McKenzie et al.

– Kinetics of the outbreak in Milwaukee were too quick to be driven solely by secondary transmission

Page 49: Overview

Conclusions Person-water-person transmission as the main

infection pathway has not been well studied– Few data exist that examines person-water-

person transmission– Studies have demonstrated a correlation

between cases of specific viral serotypes in humans and in sewage

– Provides information on a potentially important environmental intervention

Page 50: Overview

Conclusions: MethodsAnalyzing disease transmission models using

statistical techniquesAllows inferences about parameters that are

interesting and relevant – Can get at posterior distribution that allows

for calculation of relevant public health measures

Requires the modification of existing techniques– Profile likelihood to deal with large numbers

of parameters– Bayesian estimation techniques to address

the co-linearity.

Page 51: Overview

ConclusionsRisk assessments should use models

that can integrate relevant information

Health data– Epidemiology– Basic biology

Environmental data– Water quality– Fate and transport

Need a population perspective– Model-based approach


Recommended